Review



custom microrna microarray panel  (CapitalBio Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CapitalBio Corporation custom microrna microarray panel
    Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the <t>microRNA</t> signature in the training data set (42 SCLC patients).
    Custom Microrna Microarray Panel, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom microrna microarray panel/product/CapitalBio Corporation
    Average 90 stars, based on 1 article reviews
    custom microrna microarray panel - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy"

    Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0091388

    Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).
    Figure Legend Snippet: Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).

    Techniques Used: Control

    (C) Correlation between expression of U6 RNA by qRT-PCR and log 2-transformed global mean array expression. (D) Expression of U6 RNA in human normal lung (NL, n = 3) and small-cell lung cancer (SCLC, n = 42) samples by microarray method. Whiskers depict the 10 and 90 percentiles. p value is calculated by the Mann-Whitney U test.
    Figure Legend Snippet: (C) Correlation between expression of U6 RNA by qRT-PCR and log 2-transformed global mean array expression. (D) Expression of U6 RNA in human normal lung (NL, n = 3) and small-cell lung cancer (SCLC, n = 42) samples by microarray method. Whiskers depict the 10 and 90 percentiles. p value is calculated by the Mann-Whitney U test.

    Techniques Used: Expressing, Quantitative RT-PCR, Transformation Assay, Microarray, MANN-WHITNEY

    Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasisfree survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the testing data set (40 SCLC patients).
    Figure Legend Snippet: Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasisfree survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the testing data set (40 SCLC patients).

    Techniques Used: Control



    Similar Products

    custom microrna microarray panel  (CapitalBio Corporation)
    90
    CapitalBio Corporation custom microrna microarray panel
    Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the <t>microRNA</t> signature in the training data set (42 SCLC patients).
    Custom Microrna Microarray Panel, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom microrna microarray panel/product/CapitalBio Corporation
    Average 90 stars, based on 1 article reviews
    custom microrna microarray panel - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).

    Journal: PLoS ONE

    Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

    doi: 10.1371/journal.pone.0091388

    Figure Lengend Snippet: Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).

    Article Snippet: Hybridization was performed using a custom microRNA microarray panel (CapitalBio, Beijing, China), which included probes in triplicate for 924 mature human and mouse miRNA sequences and eight short oligonucleotides that possessed no homology to any known RNA sequence as external controls.

    Techniques: Control

    (C) Correlation between expression of U6 RNA by qRT-PCR and log 2-transformed global mean array expression. (D) Expression of U6 RNA in human normal lung (NL, n = 3) and small-cell lung cancer (SCLC, n = 42) samples by microarray method. Whiskers depict the 10 and 90 percentiles. p value is calculated by the Mann-Whitney U test.

    Journal: PLoS ONE

    Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

    doi: 10.1371/journal.pone.0091388

    Figure Lengend Snippet: (C) Correlation between expression of U6 RNA by qRT-PCR and log 2-transformed global mean array expression. (D) Expression of U6 RNA in human normal lung (NL, n = 3) and small-cell lung cancer (SCLC, n = 42) samples by microarray method. Whiskers depict the 10 and 90 percentiles. p value is calculated by the Mann-Whitney U test.

    Article Snippet: Hybridization was performed using a custom microRNA microarray panel (CapitalBio, Beijing, China), which included probes in triplicate for 924 mature human and mouse miRNA sequences and eight short oligonucleotides that possessed no homology to any known RNA sequence as external controls.

    Techniques: Expressing, Quantitative RT-PCR, Transformation Assay, Microarray, MANN-WHITNEY

    Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasisfree survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the testing data set (40 SCLC patients).

    Journal: PLoS ONE

    Article Title: A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

    doi: 10.1371/journal.pone.0091388

    Figure Lengend Snippet: Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasisfree survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the testing data set (40 SCLC patients).

    Article Snippet: Hybridization was performed using a custom microRNA microarray panel (CapitalBio, Beijing, China), which included probes in triplicate for 924 mature human and mouse miRNA sequences and eight short oligonucleotides that possessed no homology to any known RNA sequence as external controls.

    Techniques: Control